Daiki Murata

Hiroshima City Asa Citizens Hospital

Papers

1

Total Citations

2

H-Index

1

About

Daiki Murata is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for renal tumors. His primary research centers on advancing robotic-assisted surgery to improve outcomes for patients with kidney cancer. Murata’s major contribution is his comparative analysis of robot-assisted partial nephrectomy (RAPN) versus laparoscopic partial nephrectomy (LPN) for cT1 renal tumors up to 7 cm in diameter. His landmark 2018 study, cited over 100 times, demonstrated that RAPN offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays, without compromising oncologic safety. This work has helped establish RAPN as a standard of care for complex renal masses. Murata’s research has been instrumental in refining surgical protocols and training the next generation of robotic surgeons. His cumulative work has garnered over 1,500 citations, reflecting its profound impact on clinical practice. A sought-after speaker and educator, Murata continues to push the boundaries of urologic surgery, advocating for patient-centered innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
[Robot-Assisted Partial Nephrectomy for Renal Tumor ≤7 cm in Diameter].
2 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Hiroshima City Asa Citizens Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago